| |  | | | Eleven investigators will receive a total of $700,000 in funding for new cancer research projects through Winship Invest$, a peer-reviewed program designed to fund novel, innovative cancer research at Winship. | | Read More |
| |
| |  | | Heffner retires after 50 years with Emory | L. Thompson (Tom) Heffner, MD, professor of hematology and medical oncology, retired on April 4 after more than 50 years with Emory. Specializing in hematologic malignancies, Heffner’s career as a physician and clinical researcher has included leadership roles in national cooperative groups and clinical trials, and past president of the Georgia chapter of the American Society of Clinical Oncology.
| | | |
| | |  | | Stein retires after 40 years with Emory | Sidney Stein, MD, professor of hematology and medical oncology, retired on April 4 after more than four decades with Emory. Stein helped establish a comprehensive hemophilia program at Emory in 1986, and his leadership in the field has included service on the Governor’s Hemophilia Advisory Board. He was honored with the Sidney F. Stein, MD Chair in Hemophilia and Hemostasis in 2014.
| | | |
|
| |
| |  | | Rally grants support Winship pediatric cancer research | Six Winship pediatric cancer researchers have received grants from Rally Foundation for Childhood Cancer Research. The awards to Katharine Brock, MD, MS, Andrew Hong, MD, Xu Ji, PhD, MSPH, Hunter Jonus, PhD, Cheng-Kui Qu, MD, PhD, and Muxiang Zhou, MD, will fund research in hematological malignancies, solid tumors, palliative care and health outcomes.
| | Read More | | |
| | |  | | Prokhnevska receives AAI-Thermo Fisher Trainee Achievement Award | Nataliya Prokhnevska, a PhD student in Emory’s Immunology and Molecular Pathogenesis Graduate Program, has received an AAI-Thermo Fisher Trainee Achievement Award. Prokhnevska and fellow awardees will be honored at the annual meeting of the American Association of Immunologists, taking place in Portland, Ore., May 6-10.
| | View Awardees | | |
|
| |
| |  | | National Proton Conference features Winship speakers | Winship faculty and staff from the Department of Radiation Oncology spoke at the National Proton Conference, April 3-6, in St. Petersburg, Fla. Jeffrey Bradley, MD, Katja Langen, PhD, Amy Breakstone, MPH, and Maya Sabbagh presented on topics ranging from FLASH radiotherapy to treatment planning workflows and patient education.
| | View Agenda | | |
| | |  | | Call for proposals: Mark Foundation Emerging Leaders Award | The Mark Foundation Emerging Leader Awards support innovative cancer research from the next generation of leaders. Each grant of $250,000 per year for three years ($750,000 total) is awarded to outstanding early career investigators to advance high-impact, high-risk projects that are distinct from the current research portfolio. Letters of intent are due May 2.
| | Learn More | | |
|
| |
| |  |
| | Below are four selected Winship publications out of 70 published over the past week: |
| |
| |
| | Ellingson BM, Gerstner ER, Lassman AB, Chung C, Colman H, Cole PE, Leung D, Allen JE, Ahluwalia MS, Boxerman J, Brown M, Goldin J, Nduom E, Hassan I, Gilbert MR, Mellinghoff IK, Weller M, Chang S, Arons D, Meehan C, Selig W, Tanner K, Yung WKA, van den Bent M, Wen PY, Cloughesy TF. Hypothetical Generalized Framework for a New Imaging Endpoint of Therapeutic Activity in Early Phase Clinical Trials in Brain Tumors. Neuro-oncology. 2022; PubMed PMID: 35380705. | | View in PubMed |
| |
| |
| | Liang Z, He P, Han Y, Yun CC. Survival of stem cells and progenitors in the intestine is regulated by LPA -dependent signaling. Cellular and Molecular Gastroenterology and Hepatology. 2022; PubMed PMID: 35390517. | | View in PubMed |
| |
| |
| | Fabrizio VA, Boelens JJ, Mauguen A, Baggott C, Prabhu S, Egeler E, Mavroukakis S, Pacenta H, Phillips CL, Rossoff J, Stefanski HE, Talano JA, Moskop A, Margossian SP, Verneris MR, Myers GD, Karras NA, Brown PA, Qayed M, Hermiston M, Satwani P, Krupski C, Keating AK, Wilcox R, Rabik CA, Chinnabhandar V, Kunicki M, Goksenin AY, Mackall CL, Laetsch TW, Schultz LM, Curran KJ. Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy. Blood Advances. 2022; 6(7):1961-1968. PubMed PMID: 34788386. | | View in PubMed |
| |
| |
| | Moser-Katz T, Gavile CM, Barwick BG, Lee KP, Boise LH. PDZ proteins SCRIB and DLG1 regulate myeloma cell surface CD86 expression, growth, and survival. Molecular Cancer Research. 2022; PubMed PMID: 35380688. | | View in PubMed |
| |
| |  |
| | A selection of media stories and news coverage for Winship Cancer Institute of Emory University. |
| |
| | You are receiving Winship Roundup as a member or employee of Winship Cancer Institute. If you wish to unsubscribe, please email Winship Communications.
Emory Home |
Emory News Center |
Give to Emory |
Contact Emory
Have a story for Winship Roundup? Submit your suggestion via email. © 2021 Winship Cancer Institute of Emory University |
1365 Clifton Rd. NE, Bldg. C, Atlanta, Georgia 30322 | |
|
